-
Mashup Score: 3FDA Grants Fast Track Designation to NX-5948 for R/R WM - 3 day(s) ago
NX-5948 has received fast track designation for adults with relapsed or refractory Waldenström macroglobulinemia who received at least two prior lines of therapy.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 0RareCare - National Organization for Rare Disorders - 2 year(s) ago
NORD’s Patient Assistance Programs Since 1987, NORD has provided assistance programs to help patients obtain life-saving or life-sustaining medication they could not otherwise afford. These programs provide medication, financial assistance with insurance premiums and co-pays, diagnostic testing assistance, and travel assistance for clinical trials or consultation with disease specialists. …
Categories: Latest Headlines, Rare DiseaseTweet-
NORD is proud to offer the @WMIWMF Travel & Lodging Assistance Program! This program helps pay for travel to medical appointments & clinical trials for #WaldenstromsMacroglobulinemia. Apply by phone, email or online here: https://t.co/4c3vNNyMhd #Waldenstroms #Macroglobulinemia https://t.co/70q2JkMpLL
-
-
Mashup Score: 0
Josep Carreras Invited Lecture Dr. Ramón García-Sanz Salamanca University Hospital “The impact of Molecular characterization in hematological malignancies: The example of Waldenström’s macroglobulinemia” The Host of this webinar is Manel Esteller.
Source: ZoomCategories: Future of Medicine, Latest HeadlinesTweet-
Do not miss today 12.00h @CarrerasIJC Invited Lecture by Dr. Ramón García-Sanz @RamonGarciaSanz, University Hospital #Salamanca: molecular characterization #hematological #malignancies: example of #Waldenström’s #macroglobulinemia Free registration here: https://t.co/081i9s7kiu https://t.co/c6HoNvaBoB
-
-
Mashup Score: 4Martin’s Fight Against Waldenstrom Macroglobulnemia - NORD (National Organization for Rare Disorders) - 3 year(s) ago
I have been a healthy person my whole life. I never drank alcohol or smoked, and I had a good diet. In 2004, I began to have some questionable numbers on blood work, but my primary doctor could never really tell what was going on. My knees shook when I was referred to a hematologist and oncologist in 2010. I was given a diagnosis of Monoclonal gammopathy of undetermined significance (MGUS). I was…
Categories: Latest Headlines, Rare DiseaseTweet-
“This turned my family’s life upside down.” In honor of #RareCancerDay on 9/30, Martin shares how his #Waldenstrom #macroglobulinemia diagnosis changed his life, along with the challenges of the pandemic. Read his story on the NORD blog: https://t.co/7vvJtpYpqq #RareCancer https://t.co/goE7NyHFyL
-
-
Mashup Score: 0How Age and COVID-19 Impact a Cancer Patient’s Outlook - 5 year(s) ago
Alan Frost is 83 years old and living with Waldenstrom macroglobulinemia. His story is told here in two parts—before and after the COVID-19 outbreak.
Source: Patient PowerCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Waldenstrom Macroglobulinemia | Alan Frost is 83 years old and living with #Waldenstrom #macroglobulinemia. His story is told here in two parts—before and after the #COVID19 outbreak. #lymsm #lymphoma #coronavirus https://t.co/Zi5rW8lO1I
-
NX-5948 has received fast track designation for adults with relapsed or refractory Waldenström #macroglobulinemia who received at least two prior lines of therapy, as per a news release. https://t.co/nqfum2W3e7